Penn cell therapy pioneer Dr. Carl June wins $1M prize
Cell therapy pioneer Dr. Carl June was named the recipient of this year’s $1 million Sanford Lorraine Cross Award for his groundbreaking work in developing chimeric antigen receptor (CAR) T cell therapy.
The biennial award, given by Sioux Falls, South Dakota-based Sanford Health, recognizes “life-changing breakthroughs” and bringing emerging transformative medical innovations to patients. Sanford Health is the only health system in the country to award a $1 million prize for achievements in the medical sciences.
June is the director of the Center for Cellular Immunotherapies at the University of Pennsylvania’s Abramson Cancer Center. He is also a professor of immunology in the department of pathology and laboratory medicine at Penn’s Perelman School of Medicine.
“This is a well-deserved and exciting award for one of Penn’s most distinguished faculty members, whose pioneering research has reshaped the fight against cancer and brought fresh hope for both adults and children with the disease,” said Dr. J. Larry Jameson, Penn’s executive vice president for its health system and dean of the Perelman School of Medicine. “His contributions truly have been transformative for patients across the globe and taken the field of oncology in new and powerful directions.”
Click here to read more via The Philly Biz Journal.
Latest posts by BioBuzz Media (see all)
- Suzy Turman Joins Workforce Genetics as a Senior Life Science Talent Consultant - January 18, 2022
- Gain Therapeutics Announces R&D Day Event and Participation in Upcoming Conferences - January 18, 2022
- Orgenesis and Johns Hopkins University expand POCare in Maryland through creation of the Maryland Center for Cell Therapy Manufacturing - January 18, 2022
- Institute for Bioscience and Biotechnology Research Receives $16.8 M Investment from the National Institute of Standards and Technology - January 17, 2022
- McBee, Moore & Vanik IP: Intellectual Property Law Firm Celebrates Six Years - January 14, 2022